PEG-L-CHOP treatment is safe and effective in adult extranodal NK/T-cell lymphoma with a low rate of clinical hypersensitivity

PEG-L-CHOP treatment is safe and effective in adult extranodal NK/T-cell lymphoma with a low rate of clinical hypersensitivity

Abstract Background The combination of chemotherapy and L-asparaginase (L-ASP) treatment significantly increased survival rate in an adult patient with extranodal natural killer (NK)/T-cell lymphoma (NKTCL). However, hypersensitivity reactions of L-ASP in some patients limited its application. Polye...

Full description

Bibliographic Details
Main Authors: Wen Zheng, Yuhuan Gao, Xiaoyan Ke, Weijing Zhang, Liping Su, Hanyun Ren, Ningjing Lin, Yan Xie, Meifeng Tu, Weiping Liu, Lingyan Ping, Zhitao Ying, Chen Zhang, Lijuan Deng, Xiaopei Wang, Yuqin Song, Jun Zhu
Format: Article
Language:English
Published: BMC 2018-09-01
Series:BMC Cancer
Subjects:
Extranodal natural killer (NK)/T-cell lymphoma (NKTCL)
Polyethylene glycol-conjugated asparaginase (pegaspargase
PEG-ASP)
Therapy
Clinical trial
Online Access:http://link.springer.com/article/10.1186/s12885-018-4782-y

Internet

http://link.springer.com/article/10.1186/s12885-018-4782-y

Similar Items